News

Schering AG shares fell by over 14% and Novartis’ shares dropped nearly 3% on the news. However, although the analysis of progression free survival as assessed by central

The Global Forum, which was organized by Reconnaissance International, is the only congress in the world that brings together all the stakeholders from developing and industrialized countries. Attendees

The data, presented at The Annual Meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas, demonstrated that a single low dose of the

The 250-person sales team will call on primary care physicians who account for 40% of fluoroquinolone prescriptions written for respiratory tract infections across the US. The sales force

The program is intended to determine, in preclinical studies, the potential of skeletally targeted proteasome inhibitors as an effective and selective treatment for myeloma. Proteasome inhibitors have been

In February 2004, Dynavax and Belgium-based UCB Farchim SA, a subsidiary of UCB SA, established a strategic partnering agreement for the development and commercialization of seasonal allergy products.

According to reports, a three-month 12-patient study conducted in Texas, which is to be published in the international medical journal Cancer Letters, revealed that children taking the ADHD

The patents cover valuable vaccine components, such as the Ebola antigens and vectors. The license also covers ‘one-shot’ emergency vaccination strategies that have proven to be effective in

This data was presented via a poster session at the 229th Annual Meeting of the American Chemical Society, in San Diego, California. NeoPharm’s poster described synthesis of gemcitabine-cardiolipin